Biotech (XBI) M&A heated up in Q2 with several large deals announced or speculated with Neuro and Oncology remaining the top areas Pharma is looking...
Sierra Oncology (SRRA) an interesting name seeing insider buying into multi-month highs as a Director bought 13,500 shares at $23.03 for $310,863 on 11/24. This...